The Laboratory for Molecular Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade in Serbia focuses on personalised approaches to diagnostics, management and treatment of patients with several rare and common diseases (cystic fibrosis, alpha-1 antitrypsin deficiency, cardiovascular diseases, as well as several types of cancer). A well-established facility for genotyping and several databases correlating Serbian patient genotype and phenotype is available. The overall goal is to identify disease mechanism pathways and provide patients with timely diagnosis, assessment of risk for developing the disease, targeted and efficient therapy, and give support for possible future reproduction planning.

The Cyprus Institute of Neurology and Genetics, Translational Genetics Team is carrying out DNA sequencing alignments of Next Generation Sequencing data. The group provides specialized genetic research in the fast growing field of non-invasive prenatal diagnosis and fetal genetic analysis. The generated data is used for detection of biomarkers and the development of new tests for detecting genetic abnormalities. It should be noted that as this data is anonymized it may be not be considered as “personal data” i.e. data that identifies individuals.